ARS Pharmaceuticals, Inc. (SPRY)

NASDAQ: SPRY · Real-Time Price · USD

12.53

-0.05 (-0.40%)

At close: Apr 1, 2025, 4:00 PM

12.61

+0.08 (0.64%)

After-hours: Apr 1, 2025, 7:02 PM EDT

ARS Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,229	1,025	526	800	-	-
Market Cap Growth	94.90%	94.90%	-34.23%	-	-	-
Enterprise Value	985	821	284	839	-	-
Last Close Price	12.53	10.55	5.48	8.53	-	-
PE Ratio	156.63	128.20	-	-	-	-
PS Ratio	13.62	11.50	17535.50	607.80	-	-
PB Ratio	4.78	3.99	2.28	2.93	-	-
P/TBV Ratio	4.12	4.12	2.29	2.93	-	-
P/FCF Ratio	94.68	78.96	-	-	-	-
P/OCF Ratio	90.75	75.68	-	-	-	-
EV/Sales Ratio	11.05	9.21	9483.00	637.20	-	-
EV/FCF Ratio	75.84	63.20	-	-	-	-
Debt / Equity Ratio	0.27	0.27	0.00	0.00	0.20	1.40
Debt / FCF Ratio	5.35	5.35	-	-	-	1.10
Asset Turnover	0.31	0.31	0	0.01	0.13	-
Quick Ratio	13.79	13.79	95.80	50.59	7.34	3.03
Current Ratio	14.26	14.26	96.92	51.01	7.42	3.21
Return on Equity (ROE)	3.28%	3.28%	-21.59%	-21.84%	-77.93%	-
Return on Assets (ROA)	-0.66%	-0.66%	-16.40%	-12.56%	-27.68%	-
Return on Capital (ROIC)	-0.69%	-0.69%	-16.73%	-13.17%	-34.25%	-
Earnings Yield	0.65%	0.78%	-10.33%	-4.34%	-	-
FCF Yield	1.06%	1.27%	-11.30%	-5.04%	-	-
Buyback Yield / Dilution	-7.54%	-7.54%	-138.30%	-38.39%	-42.81%	-

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q